Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2022
Cash flows from operating activities:
(Loss) income from continuing operations	$ (60,170)	$ 14,016
Loss from discontinued operations	(7)	(132)
Net (loss) income	(60,177)	13,884
Adjustments to reconcile net (loss) income to cash used in operating activities:
Depreciation and amortization	2,306	2,054
Recovery (provision) for allowance for doubtful accounts	430	(156)
Inventory lower of cost or net realizable value	644	(134)
Stock-based compensation expense	1,979	1,225
Deferred income taxes, net of valuation allowances	8,354	(908)
Goodwill and intangible impairment charge	26,965	0
Other	(666)	1,125
Changes in operating assets and liabilities:
Trade receivables	33,966	(9,638)
Inventories	8,320	(43,259)
Prepaids and other assets	4,012	3,706
Income taxes receivable	282	(9,512)
Trade payables	(25,368)	15,200
Accrued liabilities and other liabilities, including warranty obligations	(7,027)	(1,743)
Net cash used in operating activities	(5,980)	(28,156)
Cash flows from investing activities:
Proceeds from sales and maturities of available-for-sale securities	0	17,185
Purchases of property, plant and equipment	(3,381)	(1,850)
Net cash provided by (used in) investing activities	(3,381)	15,335
Cash flows from financing activities:
Proceeds from long-term debt	17,751	1,185
Payments on long-term debt	(10,446)	(1,337)
Payments on finance lease liabilities	(30)	0	$ (60)
Proceeds from employee stock purchases	125	269
Proceeds from exercise of stock options	0	63
Tax payments related to stock award issuances	(270)	(1,322)
Net cash provided by (used in) financing activities	7,130	(1,142)
Effect of exchange rate changes	(3,330)	740
Net decrease in cash, cash equivalents and restricted cash	(5,561)	(13,223)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash at beginning of period	18,098	39,780	39,780
Cash, cash equivalents and restricted cash at end of period	12,537	26,557	18,098
Supplemental disclosure of cash flow information:
Cash paid for interest	176	60
Cash (received from) paid for income taxes, net	(514)	18,562
Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	1,335	786
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:
Cash and cash equivalents	7,311	25,218	12,872
Restricted cash	1,339	1,339	1,339
Other assets - restricted, non-current	3,887	0
Total cash, cash equivalents and restricted cash	$ 12,537	$ 26,557	$ 18,098